A Multicenter, Open Label Study to Evaluate the Safety and Efficacy of Tigecycline to Treat Complicated Skin and Skin Structure Infections (cSSSI) in Hospitalized Patients
Phase of Trial: Phase IV
Latest Information Update: 27 Dec 2007
At a glance
- Drugs Tigecycline (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 27 Dec 2007 Status change from recruiting to completed.
- 18 Jul 2007 New trial record.